Small Molecule Active Pharmaceutical Ingredient Market Report

China Small Molecule Active Pharmaceutical Ingredient Industry Market Research Report 2023-2029

  • POSTDATE：Aug 17, 2023
  • PAGES：214
  • REPORT CODE：GMM1739625
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Small Molecule Active Pharmaceutical Ingredient industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • GlaxoSmithKline

    • BASF SE

    • Catalent Inc

    • Cambrex Corporation

    • PCAS

    • Bristol-Myers Squibb

    • Patheon NV

    • Johnson Matthey

    • Sanofi SA

    • Johnson & Johnson

    • Roche

    • GILEAD Science Inc

    • AstraZeneca

    • Siegfried Holding AG

    • Pfizer

    • Boehringer Ingelheim GmbH

    • Albany Molecular Research Inc

    • Novartis AG,

    By Type:

    • Standard API

    • High Potency API

    By Application:

    • Gastrointestinal / alimentary (eg, constipation, gallstones, chemo-induced nausea or vomiting)

    • Respiratory Disorders

    • Cardiovascular Diseases

    • Infectious Diseases

    • Diabetes

    • Rheumatology / pain (eg, arthritis, muscular dystrophy)

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Small Molecule Active Pharmaceutical Ingredient Market Overview 2018-2029

    • 1.1 China Small Molecule Active Pharmaceutical Ingredient Industry Development Overview

    • 1.2 China Small Molecule Active Pharmaceutical Ingredient Industry Development History

    • 1.3 China Small Molecule Active Pharmaceutical Ingredient Industry Market Size (2018-2029)

    • 1.4 China Small Molecule Active Pharmaceutical Ingredient Market Analysis by Type from Production Side

      • 1.4.1 China Small Molecule Active Pharmaceutical Ingredient Production Volume, Production Value and Growth Rate of Standard API (2018-2029)

      • 1.4.2 China Small Molecule Active Pharmaceutical Ingredient Production Volume, Production Value and Growth Rate of High Potency API (2018-2029)

    • 1.5 China Small Molecule Active Pharmaceutical Ingredient Market Analysis by Application from Consumption End

      • 1.5.1 China Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate of Gastrointestinal / alimentary (eg, constipation, gallstones, chemo-induced nausea or vomiting) (2018-2029)

      • 1.5.2 China Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate of Respiratory Disorders (2018-2029)

      • 1.5.3 China Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate of Cardiovascular Diseases (2018-2029)

      • 1.5.4 China Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate of Infectious Diseases (2018-2029)

      • 1.5.5 China Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate of Diabetes (2018-2029)

      • 1.5.6 China Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate of Rheumatology / pain (eg, arthritis, muscular dystrophy) (2018-2029)

    • 1.6 China Small Molecule Active Pharmaceutical Ingredient Market Analysis by Region

      • 1.6.1 North China Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate from 2018-2029

    Chapter 2 China Small Molecule Active Pharmaceutical Ingredient Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Small Molecule Active Pharmaceutical Ingredient Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Small Molecule Active Pharmaceutical Ingredient Market Status and Competition Analysis in 2023

      • 2.2.3 China Small Molecule Active Pharmaceutical Ingredient Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Small Molecule Active Pharmaceutical Ingredient Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Small Molecule Active Pharmaceutical Ingredient Industry Development

    Chapter 3 Small Molecule Active Pharmaceutical IngredientIndustry Chain Analysis

    • 3.1 Small Molecule Active Pharmaceutical Ingredient Industry Chain

    • 3.2 Small Molecule Active Pharmaceutical Ingredient Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Small Molecule Active Pharmaceutical Ingredient Market

    • 3.3 Small Molecule Active Pharmaceutical Ingredient Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Small Molecule Active Pharmaceutical Ingredient Market

    Chapter 4 China Small Molecule Active Pharmaceutical Ingredient Market, by Type

    • 4.1 China Small Molecule Active Pharmaceutical Ingredient Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Small Molecule Active Pharmaceutical Ingredient Total Production Volume and Growth Rate from Production Side

    • 4.5 China Small Molecule Active Pharmaceutical Ingredient Production Volume and Growth Rate, by Type

      • 4.5.1 China Small Molecule Active Pharmaceutical Ingredient Production Volume and Growth Rate of Standard API

      • 4.5.2 China Small Molecule Active Pharmaceutical Ingredient Production Volume and Growth Rate of High Potency API

    Chapter 5 China Small Molecule Active Pharmaceutical Ingredient Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Small Molecule Active Pharmaceutical Ingredient Total Market Size and Growth Rate from Consumption End

    • 5.5 China Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate, by Application

      • 5.5.1 China Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate of Gastrointestinal / alimentary (eg, constipation, gallstones, chemo-induced nausea or vomiting)

      • 5.5.2 China Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate of Respiratory Disorders

      • 5.5.3 China Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate of Cardiovascular Diseases

      • 5.5.4 China Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate of Infectious Diseases

      • 5.5.5 China Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate of Diabetes

      • 5.5.6 China Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate of Rheumatology / pain (eg, arthritis, muscular dystrophy)

    Chapter 6 China Small Molecule Active Pharmaceutical Ingredient Market, by Region

    • 6.1 China Small Molecule Active Pharmaceutical Ingredient Production Volume and Production Value, by Region

    • 6.2 China Small Molecule Active Pharmaceutical Ingredient Sales Volume and Sales Value, by Region

    Chapter 7 North China Small Molecule Active Pharmaceutical Ingredient Market Analysis

    • 7.1 North China Small Molecule Active Pharmaceutical Ingredient Market, by Type

    • 7.2 North China Small Molecule Active Pharmaceutical Ingredient Market, by Application

    Chapter 8 Central China Small Molecule Active Pharmaceutical Ingredient Market Analysis

    • 8.1 Central China Small Molecule Active Pharmaceutical Ingredient Market, by Type

    • 8.2 Central China Small Molecule Active Pharmaceutical Ingredient Market, by Application

    Chapter 9 South China Small Molecule Active Pharmaceutical Ingredient Market Analysis

    • 9.1 South China Small Molecule Active Pharmaceutical Ingredient Market, by Type

    • 9.2 South China Small Molecule Active Pharmaceutical Ingredient Market, by Application

    Chapter 10 East China Small Molecule Active Pharmaceutical Ingredient Market Analysis

    • 10.1 East China Small Molecule Active Pharmaceutical Ingredient Market, by Type

    • 10.2 East China Small Molecule Active Pharmaceutical Ingredient Market, by Application

    Chapter 11 Northeast China Small Molecule Active Pharmaceutical Ingredient Market Analysis

    • 11.1 Northeast China Small Molecule Active Pharmaceutical Ingredient Market, by Type

    • 11.2 Northeast China Small Molecule Active Pharmaceutical Ingredient Market, by Application

    Chapter 12 Southwest China Small Molecule Active Pharmaceutical Ingredient Market Analysis

    • 12.1 Southwest China Small Molecule Active Pharmaceutical Ingredient Market, by Type

    • 12.2 Southwest China Small Molecule Active Pharmaceutical Ingredient Market, by Application

    Chapter 13 Northwest China Small Molecule Active Pharmaceutical Ingredient Market Analysis

    • 13.1 Northwest China Small Molecule Active Pharmaceutical Ingredient Market, by Type

    • 13.2 Northwest China Small Molecule Active Pharmaceutical Ingredient Market, by Application

    Chapter 14 Company Profiles

      • 14.1 GlaxoSmithKline

        • 14.1.1 GlaxoSmithKline Company Profile

        • 14.1.2 GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 BASF SE

        • 14.2.1 BASF SE Company Profile

        • 14.2.2 BASF SE Small Molecule Active Pharmaceutical Ingredient Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Catalent Inc

        • 14.3.1 Catalent Inc Company Profile

        • 14.3.2 Catalent Inc Small Molecule Active Pharmaceutical Ingredient Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Cambrex Corporation

        • 14.4.1 Cambrex Corporation Company Profile

        • 14.4.2 Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 PCAS

        • 14.5.1 PCAS Company Profile

        • 14.5.2 PCAS Small Molecule Active Pharmaceutical Ingredient Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Bristol-Myers Squibb

        • 14.6.1 Bristol-Myers Squibb Company Profile

        • 14.6.2 Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Patheon NV

        • 14.7.1 Patheon NV Company Profile

        • 14.7.2 Patheon NV Small Molecule Active Pharmaceutical Ingredient Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Johnson Matthey

        • 14.8.1 Johnson Matthey Company Profile

        • 14.8.2 Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 Sanofi SA

        • 14.9.1 Sanofi SA Company Profile

        • 14.9.2 Sanofi SA Small Molecule Active Pharmaceutical Ingredient Market Performance

        • 14.9.3 Product&Service Introduction

      • 14.10 Johnson & Johnson

        • 14.10.1 Johnson & Johnson Company Profile

        • 14.10.2 Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Market Performance

        • 14.10.3 Product&Service Introduction

      • 14.11 Roche

        • 14.11.1 Roche Company Profile

        • 14.11.2 Roche Small Molecule Active Pharmaceutical Ingredient Market Performance

        • 14.11.3 Product&Service Introduction

      • 14.12 GILEAD Science Inc

        • 14.12.1 GILEAD Science Inc Company Profile

        • 14.12.2 GILEAD Science Inc Small Molecule Active Pharmaceutical Ingredient Market Performance

        • 14.12.3 Product&Service Introduction

      • 14.13 AstraZeneca

        • 14.13.1 AstraZeneca Company Profile

        • 14.13.2 AstraZeneca Small Molecule Active Pharmaceutical Ingredient Market Performance

        • 14.13.3 Product&Service Introduction

      • 14.14 Siegfried Holding AG

        • 14.14.1 Siegfried Holding AG Company Profile

        • 14.14.2 Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Market Performance

        • 14.14.3 Product&Service Introduction

      • 14.15 Pfizer

        • 14.15.1 Pfizer Company Profile

        • 14.15.2 Pfizer Small Molecule Active Pharmaceutical Ingredient Market Performance

        • 14.15.3 Product&Service Introduction

      • 14.16 Boehringer Ingelheim GmbH

        • 14.16.1 Boehringer Ingelheim GmbH Company Profile

        • 14.16.2 Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Market Performance

        • 14.16.3 Product&Service Introduction

      • 14.17 Albany Molecular Research Inc

        • 14.17.1 Albany Molecular Research Inc Company Profile

        • 14.17.2 Albany Molecular Research Inc Small Molecule Active Pharmaceutical Ingredient Market Performance

        • 14.17.3 Product&Service Introduction

      • 14.18 Novartis AG,

        • 14.18.1 Novartis AG, Company Profile

        • 14.18.2 Novartis AG, Small Molecule Active Pharmaceutical Ingredient Market Performance

        • 14.18.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Small Molecule Active Pharmaceutical Ingredient Industry Research Conclusions

    • 15.2 Small Molecule Active Pharmaceutical Ingredient Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Small Molecule Active Pharmaceutical Ingredient Industry Market Size (2018-2029)

    • Figure China Small Molecule Active Pharmaceutical Ingredient Production Volume, Production Value and Growth Rate of Standard API (2018-2029)

    • Figure China Small Molecule Active Pharmaceutical Ingredient Production Volume, Production Value and Growth Rate of High Potency API (2018-2029)

    • Figure China Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate of Gastrointestinal / alimentary (eg, constipation, gallstones, chemo-induced nausea or vomiting) (2018-2029)

    • Figure China Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate of Respiratory Disorders (2018-2029)

    • Figure China Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate of Cardiovascular Diseases (2018-2029)

    • Figure China Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate of Infectious Diseases (2018-2029)

    • Figure China Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate of Diabetes (2018-2029)

    • Figure China Small Molecule Active Pharmaceutical Ingredient Sales Volume, Sales Value and Growth Rate of Rheumatology / pain (eg, arthritis, muscular dystrophy) (2018-2029)

    • Figure North China Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate from 2018-2029

    • Figure Central China Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate from 2018-2029

    • Figure South China Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate from 2018-2029

    • Figure East China Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate from 2018-2029

    • Figure Small Molecule Active Pharmaceutical Ingredient Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Small Molecule Active Pharmaceutical Ingredient Market Share by Type in 2018

    • Figure China Small Molecule Active Pharmaceutical Ingredient Market Share by Type in 2023

    • Figure China Small Molecule Active Pharmaceutical Ingredient Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Small Molecule Active Pharmaceutical Ingredient Production Volume and Growth Rate of Standard API (2018-2023)

    • Figure China Small Molecule Active Pharmaceutical Ingredient Production Volume and Growth Rate of High Potency API (2018-2023)

    • Figure China Small Molecule Active Pharmaceutical Ingredient Market Share by Application in 2018

    • Figure China Small Molecule Active Pharmaceutical Ingredient Market Share by Application in 2023

    • Figure China Small Molecule Active Pharmaceutical Ingredient Total Market Size and Growth Rate from Consumption End

    • Figure China Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate of Gastrointestinal / alimentary (eg, constipation, gallstones, chemo-induced nausea or vomiting) (2018-2023)

    • Figure China Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate of Respiratory Disorders (2018-2023)

    • Figure China Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate of Cardiovascular Diseases (2018-2023)

    • Figure China Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate of Infectious Diseases (2018-2023)

    • Figure China Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate of Diabetes (2018-2023)

    • Figure China Small Molecule Active Pharmaceutical Ingredient Market Size and Growth Rate of Rheumatology / pain (eg, arthritis, muscular dystrophy) (2018-2023)

    • Table China Small Molecule Active Pharmaceutical Ingredient Production Volume by Region (2018-2023)

    • Table China Small Molecule Active Pharmaceutical Ingredient Production Volume Share by Region (2018-2023)

    • Figure China Small Molecule Active Pharmaceutical Ingredient Production Volume Share by Region (2018-2023)

    • Table China Small Molecule Active Pharmaceutical Ingredient Production Value by Region (2018-2023)

    • Table China Small Molecule Active Pharmaceutical Ingredient Production Value Share by Region (2018-2023)

    • Figure China Small Molecule Active Pharmaceutical Ingredient Production Value Share by Region (2018-2023)

    • Table China Small Molecule Active Pharmaceutical Ingredient Sales Volume by Region (2018-2023)

    • Table China Small Molecule Active Pharmaceutical Ingredient Sales Volume Share by Region (2018-2023)

    • Figure China Small Molecule Active Pharmaceutical Ingredient Sales Volume Share by Region (2018-2023)

    • Table China Small Molecule Active Pharmaceutical Ingredient Sales Value by Region (2018-2023)

    • Table China Small Molecule Active Pharmaceutical Ingredient Sales Value Share by Region (2018-2023)

    • Figure China Small Molecule Active Pharmaceutical Ingredient Sales Value Share by Region (2018-2023)

    • Table North China Small Molecule Active Pharmaceutical Ingredient Production Volume by Type (2018-2023)

    • Table North China Small Molecule Active Pharmaceutical Ingredient Production Volume Share by Type (2018-2023)

    • Figure North China Small Molecule Active Pharmaceutical Ingredient Production Volume Share by Type (2018-2023)

    • Table North China Small Molecule Active Pharmaceutical Ingredient Sales Volume by Application (2018-2023)

    • Table North China Small Molecule Active Pharmaceutical Ingredient Sales Volume Share by Application (2018-2023)

    • Figure North China Small Molecule Active Pharmaceutical Ingredient Sales Volume Share by Application (2018-2023)

    • Table Central China Small Molecule Active Pharmaceutical Ingredient Production Volume by Type (2018-2023)

    • Table Central China Small Molecule Active Pharmaceutical Ingredient Production Volume Share by Type (2018-2023)

    • Figure Central China Small Molecule Active Pharmaceutical Ingredient Production Volume Share by Type (2018-2023)

    • Table Central China Small Molecule Active Pharmaceutical Ingredient Sales Volume by Application (2018-2023)

    • Table Central China Small Molecule Active Pharmaceutical Ingredient Sales Volume Share by Application (2018-2023)

    • Figure Central China Small Molecule Active Pharmaceutical Ingredient Sales Volume Share by Application (2018-2023)

    • Table South China Small Molecule Active Pharmaceutical Ingredient Production Volume by Type (2018-2023)

    • Table South China Small Molecule Active Pharmaceutical Ingredient Production Volume Share by Type (2018-2023)

    • Figure South China Small Molecule Active Pharmaceutical Ingredient Production Volume Share by Type (2018-2023)

    • Table South China Small Molecule Active Pharmaceutical Ingredient Sales Volume by Application (2018-2023)

    • Table South China Small Molecule Active Pharmaceutical Ingredient Sales Volume Share by Application (2018-2023)

    • Figure South China Small Molecule Active Pharmaceutical Ingredient Sales Volume Share by Application (2018-2023)

    • Table East China Small Molecule Active Pharmaceutical Ingredient Production Volume by Type (2018-2023)

    • Table East China Small Molecule Active Pharmaceutical Ingredient Production Volume Share by Type (2018-2023)

    • Figure East China Small Molecule Active Pharmaceutical Ingredient Production Volume Share by Type (2018-2023)

    • Table East China Small Molecule Active Pharmaceutical Ingredient Sales Volume by Application (2018-2023)

    • Table East China Small Molecule Active Pharmaceutical Ingredient Sales Volume Share by Application (2018-2023)

    • Figure East China Small Molecule Active Pharmaceutical Ingredient Sales Volume Share by Application (2018-2023)

    • Table Northeast China Small Molecule Active Pharmaceutical Ingredient Production Volume by Type (2018-2023)

    • Table Northeast China Small Molecule Active Pharmaceutical Ingredient Production Volume Share by Type (2018-2023)

    • Figure Northeast China Small Molecule Active Pharmaceutical Ingredient Production Volume Share by Type (2018-2023)

    • Table Northeast China Small Molecule Active Pharmaceutical Ingredient Sales Volume by Application (2018-2023)

    • Table Northeast China Small Molecule Active Pharmaceutical Ingredient Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Small Molecule Active Pharmaceutical Ingredient Sales Volume Share by Application (2018-2023)

    • Table Southwest China Small Molecule Active Pharmaceutical Ingredient Production Volume by Type (2018-2023)

    • Table Southwest China Small Molecule Active Pharmaceutical Ingredient Production Volume Share by Type (2018-2023)

    • Figure Southwest China Small Molecule Active Pharmaceutical Ingredient Production Volume Share by Type (2018-2023)

    • Table Southwest China Small Molecule Active Pharmaceutical Ingredient Sales Volume by Application (2018-2023)

    • Table Southwest China Small Molecule Active Pharmaceutical Ingredient Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Small Molecule Active Pharmaceutical Ingredient Sales Volume Share by Application (2018-2023)

    • Table Northwest China Small Molecule Active Pharmaceutical Ingredient Production Volume by Type (2018-2023)

    • Table Northwest China Small Molecule Active Pharmaceutical Ingredient Production Volume Share by Type (2018-2023)

    • Figure Northwest China Small Molecule Active Pharmaceutical Ingredient Production Volume Share by Type (2018-2023)

    • Table Northwest China Small Molecule Active Pharmaceutical Ingredient Sales Volume by Application (2018-2023)

    • Table Northwest China Small Molecule Active Pharmaceutical Ingredient Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Small Molecule Active Pharmaceutical Ingredient Sales Volume Share by Application (2018-2023)

    • Table GlaxoSmithKline Company Profile

    • Table GlaxoSmithKline Small Molecule Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table BASF SE Company Profile

    • Table BASF SE Small Molecule Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Catalent Inc Company Profile

    • Table Catalent Inc Small Molecule Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Cambrex Corporation Company Profile

    • Table Cambrex Corporation Small Molecule Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table PCAS Company Profile

    • Table PCAS Small Molecule Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Bristol-Myers Squibb Company Profile

    • Table Bristol-Myers Squibb Small Molecule Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Patheon NV Company Profile

    • Table Patheon NV Small Molecule Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Johnson Matthey Company Profile

    • Table Johnson Matthey Small Molecule Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Sanofi SA Company Profile

    • Table Sanofi SA Small Molecule Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson Small Molecule Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Roche Company Profile

    • Table Roche Small Molecule Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table GILEAD Science Inc Company Profile

    • Table GILEAD Science Inc Small Molecule Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table AstraZeneca Company Profile

    • Table AstraZeneca Small Molecule Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Siegfried Holding AG Company Profile

    • Table Siegfried Holding AG Small Molecule Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Pfizer Company Profile

    • Table Pfizer Small Molecule Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Boehringer Ingelheim GmbH Company Profile

    • Table Boehringer Ingelheim GmbH Small Molecule Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Albany Molecular Research Inc Company Profile

    • Table Albany Molecular Research Inc Small Molecule Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)

    • Table Novartis AG, Company Profile

    • Table Novartis AG, Small Molecule Active Pharmaceutical Ingredient Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US